ClinVar for MedGen (Select 854363) - ClinVar - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Links from MedGen

Items: 1 to 100 of 456

<< First< Prev

Page of 5

VariationLocation		Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status
Select item 25785471.	NM_032737.4(LMNB2):c.1163T>G (p.Ile388Ser) GRCh37: Chr19:2434332 GRCh38: Chr19:2434334	LMNB2	I388S	Microcephaly 27, primary, autosomal dominant, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (May 10, 2023)	criteria provided, single submitter
Select item 24270642.	NC_000019.9:g.(?_1456055)_(2456931_?)dup GRCh37: Chr19:1456055-2456931	CSNK1G2, PEAK3, ABHD17A, MBD3, MIR1909, AMH, JSRP1, LINGO3, PLK5, APC2, TMPRSS9, BTBD2, REEP6, PLEKHJ1, REXO1, MOB3A, OAZ1, KLF16, AP3D1, TIMM13, ADAT3, ONECUT3, ADAMTSL5, SF3A2, MEX3D, MKNK2, SPPL2B, TCF3, LMNB2, DOT1L, IZUMO4, C19orf25, LSM7, ATP8B3, SCAMP4, UQCR11, PCSK4		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Uncertain significance (Oct 7, 2022)	criteria provided, single submitter
Select item 24153233.	NM_032737.4(LMNB2):c.801C>T (p.His267=) GRCh37: Chr19:2435053 GRCh38: Chr19:2435055	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Sep 7, 2022)	criteria provided, single submitter
Select item 22029614.	NM_032737.4(LMNB2):c.1285G>C (p.Gly429Arg) GRCh37: Chr19:2434021 GRCh38: Chr19:2434023	LMNB2	G429R	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Uncertain significance (Aug 11, 2022)	criteria provided, single submitter
Select item 22026435.	NM_032737.4(LMNB2):c.856-12G>A GRCh37: Chr19:2434923 GRCh38: Chr19:2434925	MIR7108, LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Oct 19, 2022)	criteria provided, single submitter
Select item 21979616.	NM_032737.4(LMNB2):c.1572C>T (p.Arg524=) GRCh37: Chr19:2432432 GRCh38: Chr19:2432434	LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Mar 10, 2022)	criteria provided, single submitter
Select item 21939667.	NM_032737.4(LMNB2):c.684+14C>T GRCh37: Chr19:2438147 GRCh38: Chr19:2438149	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Oct 8, 2022)	criteria provided, single submitter
Select item 21923918.	NM_032737.4(LMNB2):c.559-19G>A GRCh37: Chr19:2438305 GRCh38: Chr19:2438307	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Dec 10, 2021)	criteria provided, single submitter
Select item 21855129.	NM_032737.4(LMNB2):c.281C>G (p.Ala94Gly) GRCh37: Chr19:2444522 GRCh38: Chr19:2444524	LMNB2	A94G	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Uncertain significance (Jul 20, 2022)	criteria provided, single submitter
Select item 218236210.	NM_032737.4(LMNB2):c.912C>T (p.Arg304=) GRCh37: Chr19:2434855 GRCh38: Chr19:2434857	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Jun 13, 2022)	criteria provided, single submitter
Select item 218141011.	NM_032737.4(LMNB2):c.716G>A (p.Arg239Gln) GRCh37: Chr19:2435138 GRCh38: Chr19:2435140	LMNB2	R239Q	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Oct 13, 2022)	criteria provided, single submitter
Select item 218090112.	NM_032737.4(LMNB2):c.66C>T (p.Ala22=) GRCh37: Chr19:2456866 GRCh38: Chr19:2456868	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Apr 18, 2022)	criteria provided, single submitter
Select item 217914613.	NM_032737.4(LMNB2):c.1437C>T (p.Ile479=) GRCh37: Chr19:2433869 GRCh38: Chr19:2433871	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Jul 25, 2022)	criteria provided, single submitter
Select item 217277914.	NM_032737.4(LMNB2):c.1446G>A (p.Glu482=) GRCh37: Chr19:2433860 GRCh38: Chr19:2433862	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Aug 28, 2022)	criteria provided, single submitter
Select item 217000915.	NM_032737.4(LMNB2):c.798G>A (p.Gln266=) GRCh37: Chr19:2435056 GRCh38: Chr19:2435058	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Jul 16, 2022)	criteria provided, single submitter
Select item 216675016.	NM_032737.4(LMNB2):c.707G>A (p.Arg236Gln) GRCh37: Chr19:2435147 GRCh38: Chr19:2435149	LMNB2	R236Q	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Uncertain significance (May 8, 2022)	criteria provided, single submitter
Select item 216394617.	NM_032737.4(LMNB2):c.477C>G (p.Ser159Arg) GRCh37: Chr19:2438454 GRCh38: Chr19:2438456	LMNB2	S159R	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Uncertain significance (May 25, 2022)	criteria provided, single submitter
Select item 216317918.	NM_032737.4(LMNB2):c.568G>C (p.Gly190Arg) GRCh37: Chr19:2438277 GRCh38: Chr19:2438279	LMNB2	G190R	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Uncertain significance (Feb 17, 2022)	criteria provided, single submitter
Select item 215961819.	NM_032737.4(LMNB2):c.1551C>T (p.Phe517=) GRCh37: Chr19:2432453 GRCh38: Chr19:2432455	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Jul 8, 2019)	criteria provided, single submitter
Select item 215942620.	NM_032737.4(LMNB2):c.814C>T (p.Arg272Trp) GRCh37: Chr19:2435040 GRCh38: Chr19:2435042	LMNB2	R272W	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Nov 1, 2022)	criteria provided, single submitter
Select item 215906121.	NM_032737.4(LMNB2):c.1591-8G>A GRCh37: Chr19:2431908 GRCh38: Chr19:2431910	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Oct 13, 2022)	criteria provided, single submitter
Select item 215384222.	NM_032737.4(LMNB2):c.1252A>C (p.Thr418Pro) GRCh37: Chr19:2434054 GRCh38: Chr19:2434056	LMNB2	T418P	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Uncertain significance (Mar 15, 2022)	criteria provided, single submitter
Select item 214957523.	NM_032737.4(LMNB2):c.260G>A (p.Arg87His) GRCh37: Chr19:2456672 GRCh38: Chr19:2456674	LMNB2	R87H	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Sep 21, 2022)	criteria provided, single submitter
Select item 214919024.	NM_032737.4(LMNB2):c.1693G>C (p.Val565Leu) GRCh37: Chr19:2431798 GRCh38: Chr19:2431800	LMNB2	V565L	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Jul 13, 2022)	criteria provided, single submitter
Select item 214763725.	NM_032737.4(LMNB2):c.1822-20TCCT[3] GRCh37: Chr19:2430955-2430958 GRCh38: Chr19:2430957-2430960	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Aug 16, 2022)	criteria provided, single submitter
Select item 214713026.	NM_032737.4(LMNB2):c.1545C>T (p.Tyr515=) GRCh37: Chr19:2432459 GRCh38: Chr19:2432461	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Feb 13, 2022)	criteria provided, single submitter
Select item 214657327.	NM_032737.4(LMNB2):c.1444G>A (p.Glu482Lys) GRCh37: Chr19:2433862 GRCh38: Chr19:2433864	LMNB2	E482K	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Feb 14, 2022)	criteria provided, single submitter
Select item 214312928.	NM_032737.4(LMNB2):c.1365C>G (p.Gly455=) GRCh37: Chr19:2433941 GRCh38: Chr19:2433943	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Apr 1, 2022)	criteria provided, single submitter
Select item 214291529.	NM_032737.4(LMNB2):c.1337G>A (p.Gly446Asp) GRCh37: Chr19:2433969 GRCh38: Chr19:2433971	LMNB2	G446D	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Sep 19, 2022)	criteria provided, single submitter
Select item 214244030.	NM_032737.4(LMNB2):c.739A>C (p.Ser247Arg) GRCh37: Chr19:2435115 GRCh38: Chr19:2435117	LMNB2	S247R	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Oct 14, 2022)	criteria provided, single submitter
Select item 214187231.	NM_032737.4(LMNB2):c.1404C>G (p.Ala468=) GRCh37: Chr19:2433902 GRCh38: Chr19:2433904	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Jul 22, 2022)	criteria provided, single submitter
Select item 210788232.	NM_032737.4(LMNB2):c.1585G>A (p.Val529Ile) GRCh37: Chr19:2432419 GRCh38: Chr19:2432421	LMNB2	V529I	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Mar 9, 2022)	criteria provided, single submitter
Select item 210638333.	NM_032737.4(LMNB2):c.1729G>A (p.Val577Met) GRCh37: Chr19:2431638 GRCh38: Chr19:2431640	LMNB2	V577M	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Apr 13, 2022)	criteria provided, single submitter
Select item 210066634.	NM_032737.4(LMNB2):c.1677C>G (p.Ser559Arg) GRCh37: Chr19:2431814 GRCh38: Chr19:2431816	LMNB2	S559R	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Benign (Oct 12, 2022)	criteria provided, single submitter
Select item 209650035.	NM_032737.4(LMNB2):c.437A>G (p.Gln146Arg) GRCh37: Chr19:2438494 GRCh38: Chr19:2438496	LMNB2	Q146R	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Sep 28, 2022)	criteria provided, single submitter
Select item 208372036.	NM_032737.4(LMNB2):c.1037G>A (p.Arg346Gln) GRCh37: Chr19:2434458 GRCh38: Chr19:2434460	LMNB2	R346Q	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Mar 31, 2022)	criteria provided, single submitter
Select item 206442437.	NM_032737.4(LMNB2):c.1744G>A (p.Val582Met) GRCh37: Chr19:2431623 GRCh38: Chr19:2431625	LMNB2	V582M	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9, Inborn genetic diseases	Uncertain significance (Jun 21, 2022)	criteria provided, multiple submitters, no conflicts
Select item 206381738.	NM_032737.4(LMNB2):c.1361C>G (p.Thr454Arg) GRCh37: Chr19:2433945 GRCh38: Chr19:2433947	LMNB2	T454R	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Uncertain significance (Dec 28, 2021)	criteria provided, single submitter
Select item 206305139.	NM_032737.4(LMNB2):c.1377C>T (p.Ser459=) GRCh37: Chr19:2433929 GRCh38: Chr19:2433931	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Oct 1, 2022)	criteria provided, single submitter
Select item 206167240.	NM_032737.4(LMNB2):c.391G>A (p.Val131Ile) GRCh37: Chr19:2444412 GRCh38: Chr19:2444414	LMNB2	V131I	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Sep 16, 2022)	criteria provided, single submitter
Select item 205841941.	NM_032737.4(LMNB2):c.1578C>T (p.Gly526=) GRCh37: Chr19:2432426 GRCh38: Chr19:2432428	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Mar 5, 2022)	criteria provided, single submitter
Select item 205826142.	NM_032737.4(LMNB2):c.1590G>A (p.Thr530=) GRCh37: Chr19:2432414 GRCh38: Chr19:2432416	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Oct 24, 2022)	criteria provided, single submitter
Select item 205018743.	NM_032737.4(LMNB2):c.481G>A (p.Val161Met) GRCh37: Chr19:2438450 GRCh38: Chr19:2438452	LMNB2	V161M	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Uncertain significance (Sep 29, 2022)	criteria provided, single submitter
Select item 204862244.	NM_032737.4(LMNB2):c.1266C>T (p.Ser422=) GRCh37: Chr19:2434040 GRCh38: Chr19:2434042	LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Sep 23, 2022)	criteria provided, single submitter
Select item 204495445.	NM_032737.4(LMNB2):c.156G>A (p.Glu52=) GRCh37: Chr19:2456776 GRCh38: Chr19:2456778	LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Aug 31, 2022)	criteria provided, single submitter
Select item 201250846.	NM_032737.4(LMNB2):c.981+14C>A GRCh37: Chr19:2434772 GRCh38: Chr19:2434774	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (May 29, 2022)	criteria provided, single submitter
Select item 200743247.	NM_032737.4(LMNB2):c.1821+15C>T GRCh37: Chr19:2431531 GRCh38: Chr19:2431533	LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Jun 16, 2022)	criteria provided, single submitter
Select item 200165148.	NM_032737.4(LMNB2):c.1847G>T (p.Gly616Val) GRCh37: Chr19:2430925 GRCh38: Chr19:2430927	LMNB2	G616V	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Jun 1, 2022)	criteria provided, single submitter
Select item 199306249.	NM_032737.4(LMNB2):c.310C>G (p.Arg104Gly) GRCh37: Chr19:2444493 GRCh38: Chr19:2444495	LMNB2	R104G	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Uncertain significance (May 11, 2022)	criteria provided, single submitter
Select item 197906950.	NM_032737.4(LMNB2):c.701G>A (p.Arg234Gln) GRCh37: Chr19:2435153 GRCh38: Chr19:2435155	LMNB2	R234Q	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Mar 14, 2022)	criteria provided, single submitter
Select item 196516351.	NM_032737.4(LMNB2):c.1336G>A (p.Gly446Ser) GRCh37: Chr19:2433970 GRCh38: Chr19:2433972	LMNB2	G446S	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Sep 30, 2022)	criteria provided, single submitter
Select item 196109752.	NM_032737.4(LMNB2):c.1711-16G>A GRCh37: Chr19:2431672 GRCh38: Chr19:2431674	LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Oct 24, 2022)	criteria provided, single submitter
Select item 194580153.	NM_032737.4(LMNB2):c.1582A>C (p.Met528Leu) GRCh37: Chr19:2432422 GRCh38: Chr19:2432424	LMNB2	M528L	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Sep 12, 2022)	criteria provided, single submitter
Select item 193419154.	NM_032737.4(LMNB2):c.559-14C>T GRCh37: Chr19:2438300 GRCh38: Chr19:2438302	LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Sep 6, 2022)	criteria provided, single submitter
Select item 192852555.	NM_032737.4(LMNB2):c.1409C>T (p.Ala470Val) GRCh37: Chr19:2433897 GRCh38: Chr19:2433899	LMNB2	A470V	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Uncertain significance (Oct 25, 2022)	criteria provided, single submitter
Select item 192533056.	NM_032737.4(LMNB2):c.1055T>A (p.Met352Lys) GRCh37: Chr19:2434440 GRCh38: Chr19:2434442	LMNB2	M352K	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Uncertain significance (Feb 2, 2022)	criteria provided, single submitter
Select item 191831457.	NM_032737.4(LMNB2):c.645G>T (p.Leu215=) GRCh37: Chr19:2438200 GRCh38: Chr19:2438202	LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Feb 14, 2022)	criteria provided, single submitter
Select item 191648658.	NM_032737.4(LMNB2):c.931C>T (p.Arg311Cys) GRCh37: Chr19:2434836 GRCh38: Chr19:2434838	LMNB2	R311C	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Uncertain significance (Oct 26, 2022)	criteria provided, single submitter
Select item 190463759.	NM_032737.4(LMNB2):c.27T>C (p.Arg9=) GRCh37: Chr19:2456905 GRCh38: Chr19:2456907	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Sep 6, 2022)	criteria provided, single submitter
Select item 189588660.	NM_032737.4(LMNB2):c.1476G>A (p.Ser492=) GRCh37: Chr19:2433830 GRCh38: Chr19:2433832	LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (May 3, 2022)	criteria provided, single submitter
Select item 172189861.	NM_032737.4(LMNB2):c.1496G>T (p.Gly499Val) GRCh37: Chr19:2432508 GRCh38: Chr19:2432510	LMNB2	G499V	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Oct 19, 2022)	criteria provided, single submitter
Select item 172156362.	NM_032737.4(LMNB2):c.687G>T (p.Glu229Asp) GRCh37: Chr19:2435167 GRCh38: Chr19:2435169	LMNB2	E229D	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance (Oct 13, 2022)	criteria provided, single submitter
Select item 171838763.	NM_032737.4(LMNB2):c.1016A>T (p.Glu339Val) GRCh37: Chr19:2434479 GRCh38: Chr19:2434481	LMNB2	E339V	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Uncertain significance (Oct 29, 2022)	criteria provided, single submitter
Select item 167224964.	NM_032737.4(LMNB2):c.1482+11A>T GRCh37: Chr19:2433813 GRCh38: Chr19:2433815	LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Benign (Jul 12, 2022)	criteria provided, single submitter
Select item 166934965.	NM_032737.4(LMNB2):c.1203-17_1203-14del GRCh37: Chr19:2434117-2434120 GRCh38: Chr19:2434119-2434122	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Sep 29, 2022)	criteria provided, single submitter
Select item 166781066.	NM_032737.4(LMNB2):c.559-7C>T GRCh37: Chr19:2438293 GRCh38: Chr19:2438295	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Aug 9, 2022)	criteria provided, single submitter
Select item 166748567.	NM_032737.4(LMNB2):c.1590+14C>T GRCh37: Chr19:2432400 GRCh38: Chr19:2432402	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Benign (Nov 1, 2022)	criteria provided, single submitter
Select item 166720868.	NM_032737.4(LMNB2):c.558+20_558+24del GRCh37: Chr19:2438349-2438353 GRCh38: Chr19:2438351-2438355	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Mar 4, 2021)	criteria provided, single submitter
Select item 166654069.	NM_032737.4(LMNB2):c.982-9C>T GRCh37: Chr19:2434522 GRCh38: Chr19:2434524	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Oct 25, 2022)	criteria provided, single submitter
Select item 166635370.	NM_032737.4(LMNB2):c.855+14G>A GRCh37: Chr19:2434985 GRCh38: Chr19:2434987	LMNB2, MIR7108		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Dec 26, 2020)	criteria provided, single submitter
Select item 166553971.	NM_032737.4(LMNB2):c.1852T>C (p.Tyr618His) GRCh37: Chr19:2430920 GRCh38: Chr19:2430922	LMNB2	Y618H	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9, Inborn genetic diseases	Conflicting interpretations of pathogenicity (Mar 1, 2023)	criteria provided, conflicting interpretations
Select item 166367872.	NM_032737.4(LMNB2):c.1350C>T (p.Ser450=) GRCh37: Chr19:2433956 GRCh38: Chr19:2433958	LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Apr 29, 2021)	criteria provided, single submitter
Select item 166310473.	NM_032737.4(LMNB2):c.1202+4C>T GRCh37: Chr19:2434289 GRCh38: Chr19:2434291	LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Feb 2, 2022)	criteria provided, single submitter
Select item 165433274.	NM_032737.4(LMNB2):c.1821+13T>C GRCh37: Chr19:2431533 GRCh38: Chr19:2431535	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Mar 19, 2022)	criteria provided, single submitter
Select item 165335375.	NM_032737.4(LMNB2):c.618G>A (p.Val206=) GRCh37: Chr19:2438227 GRCh38: Chr19:2438229	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Feb 15, 2021)	criteria provided, single submitter
Select item 165045476.	NM_032737.4(LMNB2):c.855+16G>A GRCh37: Chr19:2434983 GRCh38: Chr19:2434985	LMNB2, MIR7108		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Aug 22, 2022)	criteria provided, single submitter
Select item 164949477.	NM_032737.4(LMNB2):c.750G>C (p.Gln250His) GRCh37: Chr19:2435104 GRCh38: Chr19:2435106	LMNB2	Q250H	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Benign (Feb 19, 2022)	criteria provided, single submitter
Select item 164583478.	NM_032737.4(LMNB2):c.856-14C>G GRCh37: Chr19:2434925 GRCh38: Chr19:2434927	MIR7108, LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Benign (Oct 31, 2022)	criteria provided, single submitter
Select item 164473579.	NM_032737.4(LMNB2):c.1203-16C>T GRCh37: Chr19:2434119 GRCh38: Chr19:2434121	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Dec 8, 2021)	criteria provided, single submitter
Select item 164453780.	NM_032737.4(LMNB2):c.982-12C>T GRCh37: Chr19:2434525 GRCh38: Chr19:2434527	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Feb 3, 2022)	criteria provided, single submitter
Select item 164452481.	NM_032737.4(LMNB2):c.1535A>G (p.Glu512Gly) GRCh37: Chr19:2432469 GRCh38: Chr19:2432471	LMNB2	E512G	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to, Inborn genetic diseases	Conflicting interpretations of pathogenicity (Jul 14, 2022)	criteria provided, conflicting interpretations
Select item 163585082.	NM_032737.4(LMNB2):c.558+19G>A GRCh37: Chr19:2438354 GRCh38: Chr19:2438356	LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Apr 23, 2022)	criteria provided, single submitter
Select item 163475283.	NM_032737.4(LMNB2):c.597G>A (p.Glu199=) GRCh37: Chr19:2438248 GRCh38: Chr19:2438250	LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Aug 16, 2022)	criteria provided, single submitter
Select item 163052384.	NM_032737.4(LMNB2):c.856-17C>T GRCh37: Chr19:2434928 GRCh38: Chr19:2434930	LMNB2, MIR7108		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Dec 16, 2020)	criteria provided, single submitter
Select item 162769985.	NM_032737.4(LMNB2):c.856-10C>T GRCh37: Chr19:2434921 GRCh38: Chr19:2434923	LMNB2, MIR7108		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Jan 13, 2022)	criteria provided, single submitter
Select item 162739786.	NM_032737.4(LMNB2):c.580G>C (p.Ala194Pro) GRCh37: Chr19:2438265 GRCh38: Chr19:2438267	LMNB2	A194P	Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Feb 2, 2022)	criteria provided, single submitter
Select item 162471787.	NM_032737.4(LMNB2):c.685-5C>T GRCh37: Chr19:2435174 GRCh38: Chr19:2435176	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Benign (Jul 19, 2022)	criteria provided, single submitter
Select item 162299188.	NM_032737.4(LMNB2):c.282G>A (p.Ala94=) GRCh37: Chr19:2444521 GRCh38: Chr19:2444523	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Feb 4, 2022)	criteria provided, single submitter
Select item 161887089.	NM_032737.4(LMNB2):c.1203-17C>G GRCh37: Chr19:2434120 GRCh38: Chr19:2434122	LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Jun 5, 2022)	criteria provided, single submitter
Select item 161410390.	NM_032737.4(LMNB2):c.1482+17G>C GRCh37: Chr19:2433807 GRCh38: Chr19:2433809	LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Jul 19, 2022)	criteria provided, single submitter
Select item 160762491.	NM_032737.4(LMNB2):c.807G>C (p.Glu269Asp) GRCh37: Chr19:2435047 GRCh38: Chr19:2435049	LMNB2	E269D	Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Likely benign (Aug 10, 2022)	criteria provided, single submitter
Select item 159965892.	NM_032737.4(LMNB2):c.1483-11G>A GRCh37: Chr19:2432532 GRCh38: Chr19:2432534	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Benign (Nov 3, 2022)	criteria provided, single submitter
Select item 159962893.	NM_032737.4(LMNB2):c.1482+15C>T GRCh37: Chr19:2433809 GRCh38: Chr19:2433811	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Benign (Oct 25, 2022)	criteria provided, single submitter
Select item 159960794.	NM_032737.4(LMNB2):c.1822-17T>C GRCh37: Chr19:2430967 GRCh38: Chr19:2430969	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Benign (Oct 25, 2022)	criteria provided, single submitter
Select item 159895195.	NM_032737.4(LMNB2):c.1482+20C>T GRCh37: Chr19:2433804 GRCh38: Chr19:2433806	LMNB2		Lipodystrophy, partial, acquired, susceptibility to, Progressive myoclonic epilepsy type 9	Benign (Jan 27, 2021)	criteria provided, single submitter
Select item 159430596.	NM_032737.4(LMNB2):c.504C>T (p.Ser168=) GRCh37: Chr19:2438427 GRCh38: Chr19:2438429	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Nov 20, 2020)	criteria provided, single submitter
Select item 159412897.	NM_032737.4(LMNB2):c.249G>A (p.Glu83=) GRCh37: Chr19:2456683 GRCh38: Chr19:2456685	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Dec 14, 2021)	criteria provided, single submitter
Select item 159376498.	NM_032737.4(LMNB2):c.264+15T>C GRCh37: Chr19:2456653 GRCh38: Chr19:2456655	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Sep 13, 2022)	criteria provided, single submitter
Select item 159121699.	NM_032737.4(LMNB2):c.666G>A (p.Arg222=) GRCh37: Chr19:2438179 GRCh38: Chr19:2438181	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Sep 27, 2022)	criteria provided, single submitter
Select item 1590449100.	NM_032737.4(LMNB2):c.1083G>A (p.Thr361=) GRCh37: Chr19:2434412 GRCh38: Chr19:2434414	LMNB2		Progressive myoclonic epilepsy type 9, Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Jun 12, 2021)	criteria provided, single submitter

<< First< Prev

Page of 5